午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
TargetMol Chemicals Inc.
Firmenname:
TargetMol Chemicals Inc.
Telefon:
-+1-781-999-5354;
E-Mail:
marketing@targetmol.com
Nationalit?t:
United States
URL:
https://www.targetmol.com/
Produkte insgesamt:
32376
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
Produktkatalog
Ezetimibe phenoxy glucuronide;Ezetimibe β-D-glucuronide;Ezetimibe glucuronide
190448-57-8
C30H29F2NO9
Evogliptin tartrate;DA-1229 tartrate
1222102-51-3
C19H26F3N3O3 · (C4H6O6)
Shikonin;Isoarnebin 4;Anchusa acid;NSC 252844;Alkanna Red;(+)-Shikonin;C.I. 75535
517-89-5
C16H16O5
Ezetimibe-d4;SCH 58235 D4;Ezetimibe D4
1093659-90-5
C24H17D4F2NO3
Ezetimibe ketone;EZM-K
191330-56-0
C24H19F2NO3
F-1
2244775-31-1
C22H27ClN8O3S
Exatecan
171335-80-1
C24H22FN3O4
Etimizol
64-99-3
C9H14N4O2
FAAH inhibitor 1
326866-17-5
C24H23N3O3S3
FAAH-IN-1
1242441-47-9
C20H19ClN4OS
Etoricoxib-d4;MK-0663 D4;Etoricoxib D4;L-791456 D4
1131345-14-6
C18H11ClD4N2O2S
Etiracetam;UCB 6474
33996-58-6
C8H14N2O2
Etravirine D4;TMC-125 D4;R-165335 D4
1142095-93-9
C20H11BrD4N6O
Ezetimibe phenoxy glucuronide-D4;Ezetimibe glucuronide-D4;Ezetimibe β-D-glucuronide-D4
1426174-41-5
C30H25D4F2NO9
Dxd
1599440-33-1
C26H24FN3O6
Etamicastat hydrochloride
677773-32-9
C14H16ClF2N3OS
Ethacizine hydrochloride
57530-40-2
C22H28ClN3O3S
Endothelial lipase inhibitor-1
1466427-02-0
C22H22N4O4
Enocyanin
11029-12-2
C15H11O+
ENS-163 phosphate;Sandoz ENS 163 phosphate;Thiopilocarpine phosphate;ENS 213-163
117707-51-4
C11H19N2O5PS
Enzalutamide-d3;Enzalutamide D3;MDV3100 D3
1443331-82-5
C21H13D3F4N4O2S
EMT inhibitor-1
1638526-21-2
C12H12Cl2N2O2S
EHNA hydrochloride
58337-38-5
C14H24ClN5O
EML741
2328074-38-8
C31H49N5O2
Clorgyline hydrochloride
N-(3-(2,4-Dichlorphenoxy)propyl)-N-methyl-2-propin-1-amin-hydrochlorid
17780-75-5
C13H16Cl3NO
EMPA
680590-49-2
C23H26N4O4S
Cefprozil monohydrate
121123-17-9
C18H21N3O6S
(R)-Elagolix
834153-87-6
C32H30F5N3O5
Elenbecestat
1388651-30-6
C19H18F3N5O2S
ELN318463 racemate
851599-82-1
C19H20BrClN2O3S
Elubrixin
688763-64-6
C17H17Cl2FN4O4S
Elinogrel;PRT060128
936500-94-6
C20H15ClFN5O5S2
ELN318463;ELN 318463
851600-86-7
C19H20BrClN2O3S
EMDT oxalate
263744-72-5
C15H22N2O
EIPA hydrochloride;L593754 hydrochloride;MH 12-43 hydrochloride
1345839-28-2
C11H19Cl2N7O
eIF4A3-IN-2
2095677-20-4
C25H19Br2ClN4O2
EHMT2-IN-2
2230850-47-0
C21H22N6O
Rineterkib
1715025-32-3
C26H27BrF3N5O2
EPAC 5376753
302826-61-5
C15H8Cl2N2O3S
Eravacycline dihydrochloride;TP-434-046;TP-434 dihydrochloride
1334714-66-7
C27H32ClFN4O8
Eplivanserin
130579-75-8
C19H21FN2O2
Camptothecin;CPT;NSC-100880;(S)-(+)-Camptothecin;Campathecin
7689-03-4
C20H16N2O4
EOAI3402143
1699750-95-2
C25H28Cl2N4O3
EP1013;F1013
223568-55-6
C18H23FN2O6
Entacapone sodium salt
1047659-02-8
C14H14N3NaO5
ent-Tadalafil;ent-IC-351
629652-72-8
C22H19N3O4
ERRα antagonist-1
1072145-33-5
C21H19N3S2
ERK2 IN-1
1093061-47-2
C36H34FN7O2S
Erlotinib-d6;NSC 718781 D6;OSI-774 D6;Erlotinib D6;CP-358774 D6
1034651-23-4
C22H23N3O4
Cephalothin sodium
Cefalotinnatrium
58-71-9
C16H16N2O6S2.Na
ERK1/2 inhibitor 1
2095719-90-5
C29H32ClN5O4
Eliglustat hemitartrate
928659-70-5
C50H78N4O14
eIF4A3-IN-1
2095486-67-0
C29H23BrClN5O2
ε-Viniferin
62218-08-0
C28H22O6
Episilvestrol
697235-39-5
C34H38O13
Epertinib;S-22611
908305-13-5
C30H27ClFN5O3
Equisetin
57749-43-6
C22H31NO4
ERB-196;WAY-202196
550997-55-2
C17H10FNO2
ER21355
150452-18-9
C22H21ClN4O4
ERAP1-IN-1
865273-97-8
C20H21F3N2O5S
Eriosematin
168010-17-1
C19H20O4
Eravacycline;TP-434
1207283-85-9
C27H31FN4O8
Ethyl tosylcarbamate
Ethyl-[(4-methylphenyl)sulfonyl]carbamat
5577-13-9
C10H13NO4S
Enalapril D5 maleate;MK-421 D5 maleate
349554-02-5
C24H27D5N2O9
Enalaprilat-d5 sodium;Enalaprilat D5 Sodium Salt;MK-422 D5 Sodium Salt
1356922-29-6
C18H18D5N2NaO5
Enalaprilat D5;MK-422 D5
349554-00-3
C18H19D5N2O5
Eicosatetraynoic acid;ETYA
1191-85-1
C20H24O2
EML4-ALK kinase inhibitor 1
1373409-08-5
C31H48N8O3
EMD638683 R-Form
1184940-47-3
C18H18F2N2O4
Embramine
3565-72-8
C18H22BrNO
EMD638683 S-Form
1184940-46-2
C18H18F2N2O4
Emixustat;ACU-4429
1141777-14-1
C16H25NO2
EMT inhibitor-2
2232228-60-1
C24H26N2O8
Emixustat hydrochloride;ACU-4429 hydrochloride
1141934-97-5
C16H26ClNO2
Emtricitabine S-oxide;Emtricitabine sulfoxide;Emtricitabine Degradant-III
152128-77-3
C8H10FN3O4S
Rasagiline
136236-51-6
C12H13N
EN6
1808714-73-9
C19H14F2N4O2
Enazadrem
107361-33-1
C18H25N3O
Endomorphin 2 TFA
1276124-00-5
C34H38F3N5O7
Enniatin A1
4530-21-6
C35H61N3O9
Enniatin complex
11113-62-5
C36H63N3O9.C35H61N3O9.C34H59N3O9.C33H57N3O9
ent-Ezetimibe
1376614-99-1
C24H21F2NO3
Dacarbazine
Dacarbazin
4342-03-4
C6H10N6O
EPI-589
1147883-03-1
C14H19NO4
Eplivanserin (mixture);SR-46349 (mixture);Eplivanserin mixture
130581-13-4
C19H21FN2O2
Endoxifen (E-isomer)
114828-90-9
C25H27NO2
ESI-08
301177-43-5
C20H23N3OS
Giredestrant tartrate
2407529-33-1
C31H37F5N4O7
Erysotrine
27740-43-8
C19H23NO3
Flumethasone
Flumetason
2135-17-3
C22H28F2O5
Podofilox
1,3,3a,4,9,9a-Hexahydro-9-hydroxy-6,7-(methylendioxy)-4-(3',4',5'-trimethoxyphenyl)benz[f]isobenzofuran-3-on
518-28-5
C22H22O8
Epertinib hydrochloride;S-22611 hydrochloride
2071195-74-7
C30H28Cl2FN5O3
EP4 receptor antagonist 1
2287259-07-6
C23H21F3N4O3
Ethyl glucuronide
17685-04-0
C8H14O7
Erythromycin thiocyanate
Erythromycinthiocyanat
7704-67-8
C38H68N2O13S
p38 MAPK-IN-2
635725-16-5
C20H19ClFN5O2
Ethacrynic acid D5
1330052-59-9
C13H12Cl2O4
Etamicastat;BIA 5-453
760173-05-5
C14H15F2N3OS
Camizestrant
2222844-89-3
C24H28F4N6
Estradiol 3-sulfamate
172377-52-5
C18H25NO4S
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
Copyright 2019 ? ChemicalBook. All rights reserved